Abstract
Serotonin (5-HT) and voltage-gated potassium (KV) channels have emerged as two major factors in the pathogenesis of pulmonary arterial hypertension (PAH). In pulmonary artery smooth muscle cells (PASMC), KV channels play a major role in the regulation of pulmonary arterial tone and proliferation. Thus, activation of KV channels leads to vasodilatation and enhances apoptosis, while their inhibition is associated with vasoconstriction and proliferation in PASMC. Moreover, these channels have a prominent role as a common target for pulmonary vasoconstrictors. Modulation of these channels by vasoconstrictors involves the activation of a variety of protein kinases. Here we review the role of localization and internalization as a novel mechanism for acute regulation of KV channels and pulmonary vascular tone by agonists such as serotonin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Humbert M, Morrell NW, Archer SL et al (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S-24S
Yuan JX-J, Rubin LJ (2005) Pathogenesis of pulmonary arterial hypertension. Circulation 111:534-538
Long L, MacLean MR, Jeffery TK et al (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98:818-827
Fantozzi I, Platoshyn O, Wong AH et al (2006) Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 291:L993-L1004
Atanassoff PG Weiss BM Schmid ER Tornic M (1992) Pulmonary hypertension and dexfenfluramine Lancet 339:436
Dempsie Y, MacLean MR (2008) Pulmonary hypertension: therapeutic targets within the serotonin system. Br J Pharmacol 155:455-462
Launay JM, Hervé P, Peoch K et al (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8:1129-1135
Hervé P, Launay JM, Scrobohaci ML et al (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249-254
Eddahibi S, Humbert M, Fadel E et al. (2001) Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108:1141-1150
Sullivan CC, Du L, Chu D et al (2003) Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A 100:12331-12336
Eddahibi S, Hanoun N, Lanfumey L et al (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105:1555-1562
Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR (2001) Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935. Circ Res 89:1231-1239
Guignabert C, Raffestin B, Benferhat R et al (2005) Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 111:2812-2819
Hironaka E, Hongo M, Sakai A et al (2003) Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Cardiovasc Res 60:692-699
Yuan X-J (1995) Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. Circ Res 77:370-378
Archer S, Souil E, Dinh-Xuan AT et al (1998) Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv1.2, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101:2319-2330
Burg ED, Remillard CV, Yuan JX-J (2008) Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153(Suppl 1):S99-S111
Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE (2003) Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 93:957-964
Platoshyn O, Remillard CV, Fantozzi I et al (2004) Diversity of voltage-dependent K+ channels in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 287:L226-L238
Coppock EA, Martens JR, Tamkun MM (2001) Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels. Am J Physiol Lung Cell Mol Physiol 281:L1-L12
McMurtry MS, Bonnet S, Wu X et al (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95:830-840
Yuan X-J Wang J Juhaszova M Gaine SP Rubin L (1998) Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 351:726-727
Pozeg ZI, Michelakis ED, McMurtry MS et al (2003) In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats. Circulation 107:2037-2044
McMurtry MS, Archer SL, Altieri DC et al (2005) Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 115:1479-1491
Archer SL, Huang J, Henry T, Peterson D, Weir EK (1993) A redox-based O2 sensor in rat pulmonary vasculature. Circ Res 73:1100-1112
Shimoda LA, Sylvester JT, Sham JSK (1998) Inhibition of voltage-gated K+ current in intrapulmonary arterial myocytes by endothelin-1. Am J Physiol 274:L842-L843
Cogolludo A, Moreno L, Boscá L, Tamargo J, Pérez-Vizcaino F (2003) Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction. Role of protein kinase Cζ. Circ Res 93:656-663
Cogolludo A, Moreno L, Lodi F, Tamargo J, Perez-Vizcaino F (2005) Postnatal maturational shift from PKCζ and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction. Cardiovasc Res 66:84-93
Cogolludo A, Moreno L, Lodi F et al (2006) Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and Kv1.5 channel internalization. Circ Res 98:931-938
Wang J, Juhaszova M, Conte JV, Gaine SP, Rubin LJ, Yuan JX-J (1998) Action of fenfluramine on voltage-gated K+ channels in human pulmonary artery smooth-muscle cells. Lancet 352:290
Hong Z, Smith AJ, Archer SL et al (2005) Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Circulation 112:1494-1499
Michelakis ED, Thébaud B, Weir EK, Archer SL (2004) Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 37:1119-1136
Cogolludo A, Frazziano G, Cobeño L et al (2006) Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann N Y Acad Sci 1091:41-51
Moreno L, Frazziano G, Cogolludo A, Cobeño L, Tamargo J, Perez-Vizcaino F (2007) Role of protein kinase Czeta and its adaptor protein p62 in voltage-gated potassium channel modulation in pulmonary arteries. Mol Pharmacol 72:1301-1309
Talley EM, Lei Q, Sirois JE, Bayliss DA (2000) TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 25:399-410
Tamir H, Hsiung SC, Yu PY et al (1992) Serotonergic signalling between thyroid cells: protein kinase C and 5-HT2 receptors in the secretion and action of serotonin. Synapse 12:155-168
Moscat J, Diaz-Meco MT (2000) The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 1:399-403
Gong J, Xu J, Bezanilla M, van Huizen R, Derin R, Li M (1999) Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science 285:1565-1569
Kim Y, Uhm DY, Shin J, Chung S (2004) Modulation of delayed rectifier potassium channel by protein kinase C zeta-containing signaling complex in pheochromocytoma cells. Neuroscience 125:359-368
Shaul PW, Anderson RG (1998) Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275:L843-L851
Martens JR, Sakamoto N, Sullivan SA, Grobaski TD, Tamkun MM (2001) Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 276:8409-8414
McEwen DP, Li Q, Jackson S, Jenkins PM, Martens JR (2008) Caveolin regulates Kv1.5 trafficking to cholesterol-rich membrane microdomains. Mol Pharmacol 73:678-685
MartÃnez-Mármol R, Villalonga N, Solé L et al (2008) Multiple Kv1.5 targeting to membrane surface microdomains. Cell Physiol 217:667-673
Allen JA, Yadav PN, Roth BL (2008) Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases. Neuropharmacology 55:961-968
Zhao YY, Liu Y, Stan RV et al (2002) Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A 99:11375-11380
Huang J, Kaminski PM, Edwards JG et al (2008) Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 294:L1250-L1259
Achcar RO, Demura Y, Rai PR et al (2006) Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 129:696-705
Patel HH, Zhang S, Murray F et al (2007) Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J 21:2970-2979
Ishiguro M, Morielli AD, Zvarova K, Tranmer BI, Penar PL, Wellman GC (2006) Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity. Circ Res 99:1252-1260
Bhattacharya S, Puri S, Miledi R, Panicker MM (2002) Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc Natl Acad Sci U S A 99:14470-14475
Acknowledgments
Our research is funded by the Spanish Ministerio de Ciencia e Innovación (research grants SAF2005-03770, SAF2008-03948 and AGL2007-66108 to F.P.-V.) and by Fundación Mutua Madrileña (to A.C.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this paper
Cite this paper
Cogolludo, A., Perez-Vizcaino, F. (2010). 5-HT Receptors and KV Channel Internalization. In: Yuan, JJ., Ward, J. (eds) Membrane Receptors, Channels and Transporters in Pulmonary Circulation. Advances in Experimental Medicine and Biology, vol 661. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-500-2_25
Download citation
DOI: https://doi.org/10.1007/978-1-60761-500-2_25
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-499-9
Online ISBN: 978-1-60761-500-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)